XML 38 R12.htm IDEA: XBRL DOCUMENT v3.20.1
Stock-Based Compensation
 3 Months Ended
May 02, 2020
Share-based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
The compensation costs that have been charged against income for the 13-weeks ended May 2, 2020 and May 4, 2019 were as follows (in thousands):

13-Weeks Ended
May 2,
2020		May 4,
2019
Stock-based compensation expense by type:
Stock options
$90  $92  
Restricted stock units1,060  363  
Employee stock purchases
44  29  
Director deferred compensation23  23  
  Total stock-based compensation expense1,217  507  
Income tax benefit recognized391  113  
  Stock-based compensation expense, net of income tax$826  $394  

Expense for restricted stock units is shown net of forfeitures of $0.3 million and $1.3 million for the 13-weeks ended May 2, 2020 and May 4, 2019, respectively. 
In the 13-weeks ended May 2, 2020 and May 4, 2019, we granted the following equity awards:

13-Weeks Ended
May 2,
2020		May 4,
2019
Stock options
27,000  16,798  
Restricted stock unit awards
334,485  191,021  
Performance-based restricted stock unit awards
—  34,300  
Deferred stock units
2,143  1,027  
At May 2, 2020, the total compensation costs related to unvested restricted stock unit awards not yet recognized was $7.9 million and the weighted-average period over which such awards are expected to be recognized was 2.9 years. There were no compensation costs related to unvested stock options at May 2, 2020.
Under the 2012 Non-Employee Director Equity Plan (2012 Plan), no shares of our common stock were awarded during the 13-weeks ended May 2, 2020. A total of 13,858 shares of our common stock were awarded during the 13-weeks ended May 4, 2019, as part of the annual equity award to directors in the first quarter.
During the 13-weeks ended May 2, 2020 and May 4, 2019, 27,000 and 16,798 stock options were granted, respectively. The weighted-average grant date fair value of stock options granted during the 13-weeks ended May 2, 2020 and May 4, 2019 was $3.33 and $5.46 per share, respectively.
The number of shares purchased, the average price per share and the weighted-average grant date fair value of shares purchased through our employee stock purchase plan were as follows:
13-Weeks Ended
May 2,
2020		May 4,
2019
Shares purchased17,758  9,925  
Average price per share$9.29  $12.16  
Weighted average fair value at grant date$4.21  $3.14